INFLAMMATORY BOWEL-DISEASE - MEDICAL COST ALGORITHMS

被引:81
作者
HAY, AR
HAY, JW
机构
[1] UNIV SO CALIF,DEPT PHARMACEUT ECON & POLICY,1985 ZONAL AVE,LOS ANGELES,CA 90033
[2] SALEM MEM HOSP,SALEM,OR
关键词
CROHNS DISEASE; ULCERATIVE COLITIS; HEALTH-CARE COSTS; ALGORITHMS;
D O I
10.1097/00004836-199206000-00010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In this study we describe medical cost estimates for the two major types of inflammatory bowel disease, Crohn's disease and ulcerative colitis, using a literature-based medical decision algorithm costing methodology. Surgery and inpatient costs were estimated to account for roughly half of inflammatory bowel disease medical costs. Outpatient medical care represented only 3.0-7.1% of average cost of medical care for inflammatory bowel disease; initial diagnostic workups were only 1.5-7.8% of medical costs. Long-term complications were estimated to average $439 for ulcerative colitis, nearly twice the average for Crohn's disease. Medications averaged about 10% of total costs. The average annual medical cost per patient with Crohn's disease was estimated at $6,561 (1990 U.S. dollars). The total annual medical costs for U.S. Crohn's disease patients in 1990 was estimated at $1.0-1.2 billion. The average annual medical cost per patient with ulcerative colitis was estimated at $1,488. The total annual medical costs for U.S. patients with ulcerative colitis in 1990 was estimated at $0.4-0.6 billion.
引用
收藏
页码:318 / 327
页数:10
相关论文
共 59 条
[1]   CHOLELITHIASIS AND UROLITHIASIS IN CROHNS-DISEASE [J].
ANDERSSON, H ;
BOSAEUS, I ;
FASTH, S ;
HELLBERG, R ;
HULTEN, L .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 (02) :253-256
[2]   PROCTECTOMY FOR INFLAMMATORY BOWEL-DISEASE [J].
BAUER, JJ ;
GELERNT, IM ;
SALK, BA ;
KREEL, I .
AMERICAN JOURNAL OF SURGERY, 1986, 151 (01) :157-162
[3]  
Bayless TM, 1989, CURRENT MANAGEMENT I
[4]  
BERTEN JA, 1960, GASTROENTEROLOGY, V39, P385
[5]  
BONNEVIE OI, 1969, SCAND J GASTROENTERO, V3, P593
[6]   CLINICAL-APPEARANCE AT DIAGNOSIS OF ULCERATIVE-COLITIS AND CROHNS-DISEASE IN A REGIONAL PATIENT GROUP [J].
BOTH, H ;
TORPPEDERSEN, K ;
KREINER, S ;
HENDRIKSEN, C ;
BINDER, V .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1983, 18 (07) :987-991
[7]   EPIDEMIOLOGY OF INFLAMMATORY BOWEL-DISEASE [J].
CALKINS, BM ;
MENDELOFF, AI .
EPIDEMIOLOGIC REVIEWS, 1986, 8 :60-91
[8]   COLON CANCER, DYSPLASIA, AND SURVEILLANCE IN PATIENTS WITH ULCERATIVE-COLITIS - A CRITICAL-REVIEW [J].
COLLINS, RH ;
FELDMAN, M ;
FORDTRAN, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (26) :1654-1658
[9]   ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE [J].
DAS, KM ;
EASTWOOD, MA ;
MCMANUS, JPA ;
SIRCUS, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) :491-495
[10]   ANKYLOSING-SPONDYLITIS AND INFLAMMATORY BOWEL-DISEASE .2. PREVALENCE OF PERIPHERAL ARTHRITIS, SACROILIITIS, AND ANKYLOSING-SPONDYLITIS IN PATIENTS SUFFERING FROM INFLAMMATORY BOWEL-DISEASE [J].
DEKKERSAEYS, BJ ;
MEUWISSEN, SGM ;
VANDENBERGLOONEN, EM ;
DEHAAS, WHD ;
AGENANT, D ;
TYTGAT, GNJ .
ANNALS OF THE RHEUMATIC DISEASES, 1978, 37 (01) :33-35